File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.mehy.2020.110124
- Scopus: eid_2-s2.0-85088402103
- PMID: 32721813
- WOS: WOS:000577511800131
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: ‘The Double-Edged Sword’ – An hypothesis for Covid-19-induced salivary biomarkers
| Title | ‘The Double-Edged Sword’ – An hypothesis for Covid-19-induced salivary biomarkers |
|---|---|
| Authors | |
| Keywords | COVID-19 pandemic Saliva biomarkers SARS-CoV-2 |
| Issue Date | 2020 |
| Publisher | Churchill Livingstone. The Journal's web site is located at http://www.elsevier.com/locate/mehy |
| Citation | Medical Hypotheses, 2020, v. 143, p. article no. 110124 How to Cite? |
| Abstract | Utilising biomarkers for COVID-19 diagnosis, prediction of treatment response and overall prognostication have been investigated recently. However, these ventures have only considered the use of blood-based molecular markers. Saliva is another biofluid that warrants being applied in similar fashion with major advantages that centres on its non-invasive and repeatable collection as well as cost-efficiency. To this end, this article presents a hypothesis for the sources of biomarkers useful clinically for COVID-19 disease outcome estimation and identify the likely implications of their detection in saliva. |
| Persistent Identifier | http://hdl.handle.net/10722/284786 |
| ISSN | 2023 Impact Factor: 2.1 2023 SCImago Journal Rankings: 0.587 |
| PubMed Central ID | |
| ISI Accession Number ID |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | ADEOYE, J | - |
| dc.contributor.author | Thomson, P | - |
| dc.date.accessioned | 2020-08-07T09:02:36Z | - |
| dc.date.available | 2020-08-07T09:02:36Z | - |
| dc.date.issued | 2020 | - |
| dc.identifier.citation | Medical Hypotheses, 2020, v. 143, p. article no. 110124 | - |
| dc.identifier.issn | 0306-9877 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/284786 | - |
| dc.description.abstract | Utilising biomarkers for COVID-19 diagnosis, prediction of treatment response and overall prognostication have been investigated recently. However, these ventures have only considered the use of blood-based molecular markers. Saliva is another biofluid that warrants being applied in similar fashion with major advantages that centres on its non-invasive and repeatable collection as well as cost-efficiency. To this end, this article presents a hypothesis for the sources of biomarkers useful clinically for COVID-19 disease outcome estimation and identify the likely implications of their detection in saliva. | - |
| dc.language | eng | - |
| dc.publisher | Churchill Livingstone. The Journal's web site is located at http://www.elsevier.com/locate/mehy | - |
| dc.relation.ispartof | Medical Hypotheses | - |
| dc.subject | COVID-19 pandemic | - |
| dc.subject | Saliva biomarkers | - |
| dc.subject | SARS-CoV-2 | - |
| dc.title | ‘The Double-Edged Sword’ – An hypothesis for Covid-19-induced salivary biomarkers | - |
| dc.type | Article | - |
| dc.identifier.email | Thomson, P: thomsonp@hku.hk | - |
| dc.identifier.authority | Thomson, P=rp02327 | - |
| dc.description.nature | link_to_OA_fulltext | - |
| dc.identifier.doi | 10.1016/j.mehy.2020.110124 | - |
| dc.identifier.pmid | 32721813 | - |
| dc.identifier.pmcid | PMC7372268 | - |
| dc.identifier.scopus | eid_2-s2.0-85088402103 | - |
| dc.identifier.hkuros | 311825 | - |
| dc.identifier.volume | 143 | - |
| dc.identifier.spage | article no. 110124 | - |
| dc.identifier.epage | article no. 110124 | - |
| dc.identifier.isi | WOS:000577511800131 | - |
| dc.publisher.place | United Kingdom | - |
| dc.identifier.issnl | 0306-9877 | - |